| First Author | Zhang Z | Year | 2021 |
| Journal | Elife | Volume | 10 |
| PubMed ID | 33647234 | Mgi Jnum | J:304469 |
| Mgi Id | MGI:6508656 | Doi | 10.7554/eLife.63333 |
| Citation | Zhang Z, et al. (2021) Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice. Elife 10:e63333 |
| abstractText | Adjuvant tamoxifen therapy improves survival in breast cancer patients. Unfortunately, long-term treatment comes with side effects that impact health and quality of life, including hot flashes, changes in bone density, and fatigue. Partly due to a lack of proven animal models, the tissues and cells that mediate these negative side effects are unclear. Here, we show that mice undergoing tamoxifen treatment experience changes in temperature, bone, and movement. Single-cell RNA sequencing reveals that tamoxifen treatment induces widespread gene expression changes in the hypothalamus and preoptic area (hypothalamus-POA). These expression changes are dependent on estrogen receptor alpha (ERalpha), as conditional knockout of ERalpha in the hypothalamus-POA ablates or reverses tamoxifen-induced gene expression. Accordingly, ERalpha-deficient mice do not exhibit tamoxifen-induced changes in temperature, bone, or movement. These findings provide mechanistic insight into the effects of tamoxifen on the hypothalamus-POA and indicate that ERalpha mediates several physiological effects of tamoxifen treatment in mice. |
